Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:913-919
Published online before print February 14, 2005, doi: 10.1161/01.CIR.0000155622.68580.DC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/7/913    most recent
01.CIR.0000155622.68580.DCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ooboshi, H.
Right arrow Articles by Iida, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ooboshi, H.
Right arrow Articles by Iida, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Genes and Gene Therapy
Related Collections
Right arrow Apoptosis
Right arrow Ischemic biology - basic studies
Right arrow Acute Cerebral Infarction
Right arrow Neuroprotectors
Right arrow Gene therapy

(Circulation. 2005;111:913-919.)
© 2005 American Heart Association, Inc.


Stroke

Postischemic Gene Transfer of Interleukin-10 Protects Against Both Focal and Global Brain Ischemia

Hiroaki Ooboshi, MD, PhD; Setsuro Ibayashi, MD, PhD; Takashi Shichita, MD; Yasuhiro Kumai, MD; Junichi Takada, MD; Tetsuro Ago, MD, PhD; Shuji Arakawa, MD, PhD; Hiroshi Sugimori, MD, PhD; Masahiro Kamouchi, MD, PhD; Takanari Kitazono, MD, PhD; Mitsuo Iida, MD, PhD

From the Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Correspondence to Hiroaki Ooboshi, MD, PhD, Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan. E-mail ooboshi{at}intmed2.med.kyushu-u.ac.jp

Received August 28, 2004; revision received October 3, 2004; accepted October 26, 2004.

Background— Gene therapy may be a promising approach for treatment of brain ischemia, although the efficiency of postischemic gene therapy is not established. Our goal in this study was to examine the effects of gene transfer of interleukin-10 (IL-10), an antiinflammatory cytokine, after induction of brain ischemia.

Methods and Results— Brain ischemia was produced by either photochemical occlusion of distal middle cerebral artery for focal ischemia or bilateral carotid occlusion for global ischemia in spontaneously hypertensive rats. Adenoviral vectors encoding human IL-10 (AdIL10) or ß-galactosidase (control) were injected into the lateral ventricle 90 or 60 minutes after focal or global ischemia. Five days after ischemia, IL-10, IL-1ß, or tissue necrosis factor-{alpha} in the cerebrospinal fluid, infarct volume, infiltrations of leukocytes/macrophages in the infarct area, or hippocampal neuronal damages were determined. The transduced IL-10 was released to the cerebrospinal fluid from the ventricular wall and increased to 7623±2965 pg/mL 5 days after AdIL10 transfection. Cerebral blood flow during ischemia was not different between treatments in either focal or global ischemia. Brain infarction of the AdIL10 group was significantly smaller and infiltrations of leukocytes and macrophages were fewer in the IL-10 treatment than control. Hippocampal neurons after global ischemia were more preserved, and the terminal deoxynucleotidyl transferase–mediated dUTP-biotin in situ nick end labeling–positive cells were diminished by the IL-10 gene transfer with attenuated IL-1ß and augmented tissue necrosis factor-{alpha}.

Conclusions— Postischemic gene transfer of IL-10 into the lateral ventricle attenuated brain infarction and hippocampal damages, suggesting the promise for treatment of brain ischemia.


Key Words: apoptosis • cerebral ischemia • gene therapy • inflammation • interleukins




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
T. P. Obrenovitch
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Physiol Rev, January 1, 2008; 88(1): 211 - 247.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Yu, Z.-H. Zhang, S.-G. Wei, Y. Chu, R. M. Weiss, D. D. Heistad, and R. B. Felder
Central Gene Transfer of Interleukin-10 Reduces Hypothalamic Inflammation and Evidence of Heart Failure in Rats After Myocardial Infarction
Circ. Res., August 3, 2007; 101(3): 304 - 312.
[Abstract] [Full Text] [PDF]